Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1985-6-10
pubmed:abstractText
Enterobacter cloacae strains producing chromosomally mediated beta-lactamase constitutively show high degrees of resistance to most of the third-generation beta-lactams. It has been proposed that this resistance is due to the nonhydrolytic binding or trapping of beta-lactams by the enzyme. We found that the outer membrane of E. cloacae strain 55M indeed had permeability to cefazolin about 14-fold lower than that of Escherichia coli, and that the number of beta-lactamase molecules produced by this constitutive mutant was exceptionally large (2 X 10(5) per cell). These conditions are expected to produce a low degree of resistance, but could not explain the high resistance level of the mutant. We showed that the beta-lactamase of this strain hydrolyzed third-generation beta-lactams at measurable rates. Although the V max for these compounds was less than 0.01% of that for cefazolin, the enzyme could hydrolyze them at rates comparable to the rate for cefazolin when the substrate concentration was near 0.1 microM, a concentration thought to be physiologically relevant for the inhibition of cell growth, because of the exceptionally high affinity of the enzyme to many third-generation compounds. Calculations based on kinetic parameters of the enzyme, outer membrane permeability, and affinity toward penicillin-binding proteins succeeded in predicting the MICs for several third-generation beta-lactams. The data suggest that hydrolysis may be more important than nonhydrolytic binding for the expression of the resistant phenotype, and that studies on the susceptibility of beta-lactams to beta-lactamases should be carried out at physiologically relevant, very low concentrations of the drug, rather than the customary very high concentrations, such as 100 microM.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-13395009, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-2580479, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-314270, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-334063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-358938, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-393164, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-4287907, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6294048, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6294049, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6300016, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6327633, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6351733, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6601169, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6808912, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6972193, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6979593, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-6982680, http://linkedlifedata.com/resource/pubmed/commentcorrection/3873215-7002896
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
393-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.